论文部分内容阅读
目的观察性激素补充疗法治疗女性围绝经期综合征患者的临床效果。方法选取医院收治的女性围绝经期综合征患者90例作为研究对象,随机分为试验组和对照组,每组45例。对照组采取谷维素治疗方案,试验组采取性激素补充疗法。观察2组临床疗效和生存质量评分。结果试验组总有效率为97.78%,高于对照组的75.56%(P<0.05);接受治疗后,2组生存质量评分较治疗前均下降,试验组评分值为(31.23±3.35)低于对照组的(41.16±3.87)(P<0.05)。结论性激素补充疗法治疗女性围绝经期综合征患者的临床疗效显著,可改善患者的生存质量,值得临床推广。
Objective To observe the clinical effect of sex hormone replacement therapy in the treatment of women with perimenopausal syndrome. Methods Ninety female patients with perimenopausal syndrome admitted to the hospital were selected as research subjects and randomly divided into experimental group and control group with 45 cases in each group. Control group to take oryzanol treatment program, the experimental group to take hormone replacement therapy. The clinical efficacy and quality of life scores of two groups were observed. Results The total effective rate in the experimental group was 97.78%, which was higher than that in the control group (75.56%, P <0.05). After receiving the treatment, the two groups’ quality of life scores decreased compared with that before treatment, and the score of the experimental group was (31.23 ± 3.35) The control group (41.16 ± 3.87) (P <0.05). Conclusions The clinical effect of sex hormone replacement therapy in the treatment of perimenopausal syndrome in women is significant, which can improve the quality of life of patients and deserve clinical promotion.